Latest News

Why Visteon Stock Is Drawing Fresh Attention Visteon (VC) is back on many investors’ radars after a period of mixed share performance, with the stock showing a 9.4% total return over the past year but weaker recent momentum. At a last close of US$90.67, Visteon sits against a backdrop of annual revenue of US$3.8b and net income of US$201 million, giving investors concrete numbers to weigh against recent volatility. See our latest analysis for Visteon. Recent trading has been softer, with a 30...

If you are wondering whether L3Harris Technologies is priced fairly after its recent run, this article will help you make sense of where the stock sits on the value spectrum. The share price recently closed at US$364.26, with returns of 3.9% over 30 days and 19.6% year to date, while the 1 year return stands at 77.3% and the 5 year figure at 109.6%. Recent news around L3Harris has focused on its role in defense and aerospace, with investors watching how contract activity and sector sentiment...

On March 9, 2026, Archer-Daniels-Midland expanded its Board to 13 members by appointing former LyondellBasell CFO Michael McMurray, who will serve on the Audit and Sustainability and Technology committees. By adding a director with extensive financial and industrial experience, ADM is signaling a reinforced focus on governance, risk oversight, and long-term sustainability priorities. We’ll now examine how McMurray’s appointment to ADM’s Board could influence the company’s investment...

Structure Therapeutics (GPCR) reported fourth quarter net income of US$33 million, compared with a net loss of US$36.48 million a year earlier, marking a clear shift in its recent financial results. See our latest analysis for Structure Therapeutics. Despite the shift to quarterly net income, Structure Therapeutics’ recent share price return has softened, with a 30 day share price return of 26.26% and a year to date share price return of 14.56%. By contrast, the 1 year total shareholder...

Grand City Properties (XTRA:GYC) has drawn investor attention after recent trading left the shares with a year to date return of about 0.9% and a 1 year total return close to 2.1%. See our latest analysis for Grand City Properties. Despite the recent 1-day share price return of a 4.8% decline and a 7-day share price return of a 5.9% decline from €9.71, Grand City Properties still shows a positive year to date share price return and a 3-year total shareholder return of 10.59%. This suggests...

Mercedes-Benz Group (XTRA:MBG) is back in focus after its latest share buyback activity, arriving shortly after full year 2025 results that showed €107.589b in sales and €5.141b in net income. See our latest analysis for Mercedes-Benz Group. Despite the ongoing buybacks and recent earnings release, recent price action has been soft, with a 30 day share price return of a 5.9% decline and a year to date share price return of an 11.4% decline. However, the 5 year total shareholder return of...

Why Madrigal Pharmaceuticals Is On Investors’ Radar Madrigal Pharmaceuticals (MDGL) has attracted fresh attention after recent market moves, with the share price near US$431.53 and returns showing mixed results over the past year and past 3 months. For investors tracking performance, the stock shows a 1 day return of about a 0.3% decline and a 7 day return of roughly a 0.8% decline, while the past month and past 3 months reflect deeper pullbacks. See our latest analysis for Madrigal...

Regulatory momentum in immunology and infectious diseases Sanofi (ENXTPA:SAN) is back in focus after European regulators issued positive opinions on two key therapies: Dupixent for pediatric chronic spontaneous urticaria and Acoziborole Winthrop for gambiense sleeping sickness. For investors, these regulatory milestones highlight Sanofi’s progress in immunology and infectious diseases, areas that can shape long term portfolio perceptions, especially given the company’s established presence...

Bravida Holding (OM:BRAV) is back on investor radar after Bravida Sweden was commissioned by NCC to handle plumbing and HVAC work for a new wastewater treatment plant in Åkersberga outside Stockholm. See our latest analysis for Bravida Holding. The latest contract news lands as Bravida Holding’s share price sits at SEK104.4, with a 30-day share price return of 12.14% and an 18.10% year-to-date share price return. The 1-year total shareholder return stands at 19.61%, suggesting momentum has...

If you are wondering whether Chubb's current share price reflects its true worth, you are not alone. Many investors are asking if the recent price level still offers value. Chubb shares last closed at US$322.76, with returns of 4.1% year to date and 15.2% over the past year, while the stock shows a 3.4% decline over 7 days and a 1.0% decline over 30 days that may have caught your eye. Recent headlines around Chubb have focused on its position in the insurance space and how investors are...

Why Danske Bank (CPSE:DANSKE) is drawing fresh attention Recent share price moves in Danske Bank (CPSE:DANSKE), including a decline over the past month along with a gain in the past 3 months, are prompting investors to reassess the bank’s current valuation and fundamentals. See our latest analysis for Danske Bank. The recent 1 month share price return of a 5.72% decline and 7 day softness sit against a year to date share price return of 1.16%. At the same time, the 1 year total shareholder...

Wondering if Exelon at around US$48.84 is giving you fair value right now, or if the market is missing something important about this utility giant. The stock has been relatively steady over the past week with a 0.8% decline, while its 30 day return of 11.1% and 1 year return of 18.7% may catch the eye of investors who are thinking about growth potential or shifting risk perceptions. Those moves sit against a wider backdrop of ongoing interest in regulated utilities. In this area, investors...

In early March 2026, Hewlett Packard Enterprise reported past first-quarter results showing higher sales of US$8,425 million, raised its full-year 2026 earnings guidance, continued an extensive multi-year share buyback now totaling about US$12.86 billion, and affirmed a regular dividend of US$0.1425 per share. A key insight is that networking has become a central earnings engine, helping drive record per-share profits and stronger guidance, while the company simultaneously returns large...

If you are wondering whether Ralph Lauren's share price still offers value after a strong run, this article will walk through what the current market price might be implying about the business. The stock last closed at US$338.95. While the share price shows a 5.8% decline over 7 days and a 2.6% decline over 30 days, it also shows a 6.5% decline year to date, a 52.4% gain over 1 year, and more than 3x over 3 years. Recent coverage around Ralph Lauren has focused on its brand strength, product...

Recent performance snapshot OSG (TSE:6136) has drawn investor attention after a mixed stretch in its share performance, with negative 1 day, week and month returns, contrasted by gains over the past 3 months, year to date and past year. See our latest analysis for OSG. Recent selling pressure, including a 1 day share price return decline of 2.92% and a 1 month share price return decline of 6.12%, sits against a stronger backdrop, with a 3 month share price return of 9.41% and a 1 year total...

Perimeter Solutions, Inc. reported past fourth-quarter 2025 sales of US$102.75 million, up from US$86.23 million a year earlier, but swung to a net loss of US$140.23 million and a basic loss per share of US$0.94 from prior-year earnings. For 2025 as a whole, the company increased sales to US$652.86 million while recording a much larger net loss of US$206.37 million, against the backdrop of its role as the sole aerial fire-retardant supplier under a new five-year U.S. Department of...

Gallagher (NYSE:AJG) released its 2026 Employee Communications Report highlighting a widespread lack of structured change management communication strategies. The report finds internal communications teams are increasingly overwhelmed, raising risks around leadership trust and employee burnout. The findings point to an emerging organizational risk that has attracted limited attention compared with topics like deals or quarterly earnings. For investors looking at Gallagher (NYSE:AJG), this...

America First Refining has broken ground on what is described as the first major US refinery project in nearly 50 years. The project highlights renewed attention on domestic refining capacity and long term US energy independence goals. Marathon Petroleum (NYSE:MPC), the largest US refiner by capacity, sits at the center of these shifts given its scale and link to American shale oil. For you as an investor, this new refinery project puts a fresh spotlight on the core business of Marathon...

Curaleaf Holdings, Inc. has released its fourth-quarter and full-year 2025 results, reporting Q4 revenue of US$333.07 million and a net loss of US$59.82 million, while full-year revenue reached US$1.27 billion with a net loss of US$231.07 million. The contrast between quarterly revenue growth and a smaller Q4 loss versus a full-year revenue decline and higher annual net loss highlights ongoing pressure on the company’s path toward profitability. We’ll now examine how the full-year revenue...

Pratt & Whitney, an RTX (NYSE:RTX) business, received a follow on contract to supply TJ150 turbojet engines for Leidos Dynetics' AGM-190A small cruise missile program. The contract expands RTX's role in next generation autonomous weapon systems and highlights the use of additive manufacturing in engine development. For you as an RTX watcher, this contract sits in the core of the company’s defense profile, where Pratt & Whitney focuses on propulsion for military platforms. Interest in...

Why ERAS-0015 is at the center of the story Erasca (ERAS) has just exercised its option to secure worldwide rights to its pan RAS molecular glue ERAS-0015 by expanding its license with Joyo Pharmatech to cover China, Hong Kong, and Macau. This follows a recent clinical trial collaboration with Tango Therapeutics involving ERAS-0015 and increased analyst attention tied to upcoming Phase 1 data, which helps explain why the stock is attracting more investor focus. See our latest analysis for...

FTAI Aviation (FTAI) is back on traders’ radar after a Q4 2025 earnings miss was followed by a 6.14% share price jump, upbeat 2026 guidance, and fresh leadership appointments in key finance roles. See our latest analysis for FTAI Aviation. That Q4 earnings miss and the leadership reshuffle come after a strong run, with a 90 day share price return of 42.71% and a very large 3 year total shareholder return. The recent 7 day pullback of 8.13% looks more like a pause than a change in...

C3.ai (AI) is back in focus after quarterly results showing a 46% year on year revenue drop, weaker guidance for the year ahead, and a restructuring plan featuring layoffs and cost cuts. See our latest analysis for C3.ai. Those weak quarterly numbers and the restructuring plan help explain why C3.ai’s 30 day share price return is 20.45% lower and its 1 year total shareholder return is 57.17% lower. This signals fading momentum despite new product launches and an upcoming conference...

Paramount Resources (TSX:POU) has drawn fresh attention after Senior Officer Rodrigo Sousa sold 60,000 Class A shares at around $30, trimming his stake by 14.3%, a move investors often watch closely. See our latest analysis for Paramount Resources. That sale comes on the back of a strong run, with Paramount Resources posting a 15.1% 1 month share price return and a 22.7% year to date share price return at around CA$29.58. Its 1 year total shareholder return of 83.6% and very large 5 year...